FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Sector 10, Inc. Stock AnalysisComprehensive stock analysis for Sector 10, Inc. (SECI) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisSECI
SECI
Sector 10, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
SECI
Home🔹Stocks🔹Sector 10, Inc.

Sector 10, Inc.

🇺🇸SECI•OTC

Sector 10, Inc.

🇺🇸SECI•OTC
Market cap
$31
Sentiment

Your view on SECI

Mkt Cap
$31
Sentiment
Your view
SECI
Sector 10, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
SECI
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Sector 10, Inc.

Industry
Medical - Distribution
Sector
Healthcare
CEO
Pericles DeAvila
Headquarters
10900 NE 4th Street, Bellevue, WA, US
Industry
Medical - Distribution
Sector
Healthcare
CEO
Pericles DeAvila
Headquarters
10900 NE 4th Street, Bellevue, WA, US
Description

Sector 10, Inc., a development stage company, markets MRU – SRU product lines and various solutions related to mobile assets. The company was founded in 2002 and is based in Bellevue, Washington.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Sector 10, Inc., and the rating behind it. SECI last traded at $0.0001, 0.0× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Sector 10, Inc.. Starting points for Sector 10, Inc.: P/E 0.0, EPS $0.02, beta 16675.40 — an Medical - Distribution name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Sector 10, Inc.. Sector 10, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Sector 10, Inc.. Trailing twelve-month EPS for Sector 10, Inc. stands at $0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Sector 10, Inc.. Sector 10, Inc. has reported as a listed company since 2006. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Sector 10, Inc. valued side by side against its closest peers. Sector 10, Inc. is measured against Medical - Distribution peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Sector 10, Inc., and how their positions are changing. At a $31 market value, institutional positions materially move Sector 10, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Sector 10, Inc. executives and directors. Shares of Sector 10, Inc. have traded between $0.0001 and $0.0001 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Sector 10, Inc.. Sector 10, Inc. is a $31 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Sector 10, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Sector 10, Inc.. Coverage tracks Sector 10, Inc. within Medical - Distribution (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • AFIB — Acutus Medical, Inc.
  • ARDS — Aridis Pharmaceuticals, Inc.
  • CGHC — Capital Group Holdings, Inc.
  • EVLO — Evelo Biosciences, Inc.
  • HSTC — HST Global, Inc.
  • INFIQ — Infinity Pharmaceuticals, Inc.
  • LFPI — LifePoint, Inc.

More Medical - Distribution companies

  • EXHI — Exlites Holdings International, Inc.
  • GALNF — Galenica AG
  • HIGR — Hi-Great Group Holding Company
  • HSIC — Henry Schein, Inc.
  • IUSDF — AS ONE Corporation
  • MAHLY — MediPal Holdings Corporation
  • MCIC — MultiCorp International, Inc.
  • MCK — McKesson Corporation
  • MEDOF — Medios AG
  • MEPDF — MediPal Holdings Corporation
  • NSVGF — Nass Valley Gateway Ltd.
  • PDRX — PD-Rx Pharmaceuticals, Inc.

News

Latest Market News